Intervention not reported
Change in % of women accepting family planning methods · Facilities providing primary health services
It is very uncertain whether the intervention changes change in % of women accepting family planning methods (very low certainty).
1 finding from 1 review
no estimate extracted
19 participants
Very low
Intervention not reported
Childrens anthropometric outcomes
The intervention probably leads to lower childrens anthropometric outcomes (moderate certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Quantity of service provision ‐ number of outpatients visits, specialist visits, or hospitalisations · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
Service quality · healthcare providers working in outpatient healthcare settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient outcomes ‐ people with mental illness · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
Healthcare provider outcomes (such as work morale or workload) · healthcare providers working in outpatient healthcare settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
no estimate extracted
2 participants
Very low
Unintended or adverse effects · healthcare providers working in outpatient healthcare settings
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
Overall survival · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
It is very uncertain whether non‐specialist‐led changes overall survival compared with specialist‐led follow‐up after primary cancer treatment (very low certainty).
1 finding from 1 review
HR 1.21 [0.68, 2.15]
603 participants
Very low
Overall survival · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life (HRQoL) · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Anxiety · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Depression · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Costs · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
1 finding from 1 review
no estimate extracted
1691 participants
Very low
Health‐related quality of life, (at 12 months' · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
Non‐specialist‐led showed no clear difference in health‐related quality of life, (at 12 months' compared with specialist‐led follow‐up after primary cancer treatment (low certainty).
1 finding from 1 review
MD 1.06
605 participants
Low
Anxiety · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
Non‐specialist‐led showed no clear difference in anxiety (at 12 months' compared with specialist‐led follow‐up after primary cancer treatment (moderate certainty).
1 finding from 1 review
MD 0.03
1266 participants
Moderate
Depressive symptoms · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
Non‐specialist‐led showed no clear difference in depression (at 12 months) HADS‐Depression subscale (higher scores… compared with specialist‐led follow‐up after primary cancer treatment (high certainty).
1 finding from 1 review
MD 0.03
1266 participants
High
Costs · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
1 finding from 1 review
no estimate extracted
1756 participants
Very low